litlas
ログインアカウント作成

John C. Davis

1952–2025 年に発表

別表記
John C Davis
73
論文数
22,750
被引用数
62
h 指数
70
i10 指数

被引用数

John C. Davis の年別被引用数1966 年: 被引用 1 件1967 年: 被引用 3 件1968 年: 被引用 1 件1969 年: 被引用 2 件1970 年: 被引用 2 件1972 年: 被引用 4 件1973 年: 被引用 2 件1974 年: 被引用 2 件1975 年: 被引用 5 件1976 年: 被引用 9 件1977 年: 被引用 7 件1978 年: 被引用 4 件1979 年: 被引用 5 件1980 年: 被引用 12 件1981 年: 被引用 8 件1982 年: 被引用 9 件1983 年: 被引用 16 件1984 年: 被引用 17 件1985 年: 被引用 9 件1986 年: 被引用 15 件1987 年: 被引用 13 件1988 年: 被引用 18 件1989 年: 被引用 27 件1990 年: 被引用 17 件1991 年: 被引用 23 件1992 年: 被引用 29 件1993 年: 被引用 28 件1994 年: 被引用 26 件1995 年: 被引用 26 件1996 年: 被引用 35 件1997 年: 被引用 22 件1998 年: 被引用 27 件1999 年: 被引用 25 件2000 年: 被引用 35 件2001 年: 被引用 49 件2002 年: 被引用 47 件2003 年: 被引用 63 件2004 年: 被引用 84 件2005 年: 被引用 127 件2006 年: 被引用 128 件2007 年: 被引用 145 件2008 年: 被引用 176 件2009 年: 被引用 160 件2010 年: 被引用 197 件2011 年: 被引用 237 件2012 年: 被引用 173 件2013 年: 被引用 166 件2014 年: 被引用 153 件2015 年: 被引用 144 件2016 年: 被引用 150 件2017 年: 被引用 157 件2018 年: 被引用 129 件2019 年: 被引用 356 件2020 年: 被引用 383 件2021 年: 被引用 306 件2022 年: 被引用 230 件2023 年: 被引用 171 件2024 年: 被引用 237 件2025 年: 被引用 106 件2026 年: 被引用 2 件1971 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,436 件、この内訳の 20.8%イギリス: 引用元論文 551 件、この内訳の 8%ドイツ: 引用元論文 495 件、この内訳の 7.2%オランダ: 引用元論文 376 件、この内訳の 5.4%フランス: 引用元論文 360 件、この内訳の 5.2%中国: 引用元論文 351 件、この内訳の 5.1%カナダ: 引用元論文 345 件、この内訳の 5%イタリア: 引用元論文 266 件、この内訳の 3.9%スペイン: 引用元論文 204 件、この内訳の 3%オーストラリア: 引用元論文 190 件、この内訳の 2.8%ベルギー: 引用元論文 147 件、この内訳の 2.1%スイス: 引用元論文 130 件、この内訳の 1.9%
0%20.8%その他 29.6%

機関

分野

  • Medicine53.3%
  • Computer Science10.3%
  • Environmental Science9.7%
  • Immunology and Microbiology7.6%
  • Earth and Planetary Sciences5.8%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • その他8.5%

トピック

  • Spondyloarthritis Studies and Treatments9.8%
  • Rheumatoid Arthritis Research and Therapies8.1%
  • Geochemistry and Geologic Mapping3.7%
  • Systemic Lupus Erythematosus Research3.4%
  • Vasculitis and related conditions3.1%
  • Psoriasis: Treatment and Pathogenesis3.1%
  • その他68.8%

共著者

全論文

検索で開く
  1. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

    著者: Cédric Lukas, Robert Landewé, Joachim Sieper, Maxime Dougados, John C. Davis, Joseph M. Braun, S van der Linden, Désirée van der Heijde - Annals of the Rheumatic Diseases 2008 被引用: 1,055

  2. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    著者: Martín Rudwaleit, R. Landewé, Désirée van der Heijde, Joachim Listing, J. Brandt, Joseph M. Braun, R Burgos-Vargas, Eduardo Collantes‐Estévez, John C. Davis, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Irene E. van der Horst‐Bruinsma, Robert D. Inman, Muhammad Asim Khan, Marjatta Leirisalo‐Repo, S. van der Linden, Walter P. Maksymowych, Herman Mielants, Ignazio Olivieri, R D Sturrock, Kurt De Vlam, Joachim Sieper - Annals of the Rheumatic Diseases 2009 被引用: 943

  3. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

    著者: Kenneth Kalunian, Joan T. Merrill, Romeo Maciuca, Jacqueline McBride, Michael J. Townsend, Xiaohui Wei, John C. Davis, William P. Kennedy - Annals of the Rheumatic Diseases 2015 被引用: 339

  4. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis

    著者: John C. Davis, S Manzi, Cheryl Yarboro, Joan E. Rairie, Iain B. McInnes, D Averthelyi, Dominick Sinicropi, Victoria Hale, James E. Balow, H A Austin, Dimitrios T. Boumpas, John H. Klippel - Lupus 1999 被引用: 233

  5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

    著者: Désirée van der Heijde, Alan Kivitz, Michael Schiff, Joachim Sieper, Ben A. C. Dijkmans, Jürgen Braun, Maxime Dougados, John D. Reveille, Robert Wong, H. Küpper, John C. Davis - Arthritis & Rheumatism 2006 被引用: 878

  6. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

    著者: Peter A. Merkel, Gang Xie, Paul A. Monach, Xuemei Ji, Dominic J. Ciavatta, Jinyoung Byun, Benjamin D. Pinder, Ai Zhao, Jinyi Zhang, Yohannes Tadesse, David C. Qian, Matthew T. Weirauch, Rajan P. Nair, Lam C. Tsoi, Christian Pagnoux, Simon Carette, Sharon A. Chung, David Cuthbertson, John C. Davis, Paul F. Dellaripa, Lindsy Forbess, Ora Gewurz‐Singer, Gary S. Hoffman, Nader Khalidi, Curry L. Koening, Carol A. Langford, Alfred Mahr, Carol A. McAlear, Larry W. Moreland, Philip Seo, Ulrich Specks, Robert Spiera, Antoine G. Sreih, E. William St. Clair, John H. Stone, Steven R. Ytterberg, James T. Elder, Jia Qu, Toshiki Ochi, Naoto Hirano, Jeffrey C. Edberg, Ronald J. Falk, Christopher I. Amos, Katherine A. Siminovitch - Arthritis & Rheumatology 2016 被引用: 178

  7. Statistics and Data Analysis in Geology

    著者: Robert H. Shumway, John C. Davis - Technometrics 1987 被引用: 4,776

  8. A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    著者: John H. Stone, Gary S. Hoffman, Peter A. Merkel, Yuan‐I Min, Misty L. Uhlfelder, David B. Hellmann, Ulrich Specks, Nancy B. Allen, John C. Davis, Robert Spiera, Leonard H. Calabrese, Fredrick M. Wigley, N Maiden, R. Valente, John L. Niles, Kenneth H. Fye, Joseph W. McCune, E. William St. Clair, Raashid Luqmani, for the International Network for the Study of the Systemic Vasculitides (INSSYS) - Arthritis & Rheumatism 2001 被引用: 466

  9. Introduction to statistical pattern recognition

    著者: John C. Davis - Computers & Geosciences 1996 被引用: 463

  10. Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE

    著者: William P. Kennedy, Romeo Maciuca, Kristen Wolslegel, Wei Tew, Alexander R. Abbas, Christina Chaivorapol, Alyssa Morimoto, Jacqueline McBride, Paul Brunetta, Bruce C. Richardson, John C. Davis, Timothy W. Behrens, Michael J. Townsend - Lupus Science & Medicine 2015 被引用: 157

  11. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

    著者: John C. Davis, Désirée van der Heijde, Jürgen Braun, Maxime Dougados, John J. Cush, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert D. Inman, Wayne Tsuji, for the Enbrel Ankylosing Spondylitis Study Group - Arthritis & Rheumatism 2003 被引用: 763

  12. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    著者: Rui Jin, Laura Diekman, John D. Reveille, Xiaodong Zhou, Matthew A. Brown, Evgeny A. Glazov, Ran Duan, Alison Dowling, Gethin Thomas, Paul Leo, Patrick Danoy, Anne-Marie Sims, Emma L. Duncan, Jacqueline Taylor, Tracey Doan, Linda A. Bradbury, Johanna Hadler, Karena Pryce, David M. Evans, Sue M Ring, Matthew A. Brown, Tugce Karaderi, Claire Farrar, David Harvey, B P Wordsworth, Louise Appleton, Jennifer J. Pointon, John C. Davis, R Mogg, Millicent Stone, Emma Pomeroy, Laurie Savage, Panos Deloukas, Leena Peltonen, Pamela Whittaker, Vasudev Kumanduri, Walter P. Maksymowych, Robert D. Inman, Millicent Stone - Nature Genetics 2010 被引用: 668

  13. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

    著者: Robert D. Inman, John C. Davis, Désirée van der Heijde, Laura Diekman, Joachim Sieper, Sung Il Kim, M. Mack, John Han, Sudha Visvanathan, Zhenhua Xu, Benjamin Hsu, Anna Beutler, Jürgen Braun - Arthritis & Rheumatism 2008 被引用: 593

  14. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice

    著者: Chang Li, Kevin A. Goncalves, Tamás Raskó, Amit Pande, Sucheol Gil, Zhinan Liu, Zsuzsanna Izsvák, Thalia Papayannopoulou, John C. Davis, Hans‐Peter Kiem, André Lieber - Blood Advances 2021 被引用: 20

  15. Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)

    著者: Philip Seo, Yuan‐I Min, Janet T. Holbrook, Gary S. Hoffman, Peter A. Merkel, Robert Spiera, John C. Davis, Steven R. Ytterberg, E. William St. Clair, W. Joseph McCune, Ulrich Specks, Nancy B. Allen, Raashid Luqmani, John H. Stone - Arthritis & Rheumatism 2005 被引用: 204

  16. Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

    著者: Jennifer D. Gorman, Kenneth E. Sack, John C. Davis - New England Journal of Medicine 2002 被引用: 707

  17. ANCA Are Detectable in Nearly All Patients with Active Severe Wegener’s Granulomatosis

    著者: Javier D. Finkielman, Augustine S. Lee, Amber M. Hummel, Margaret A. Viss, G.L. Jacob, Henry A. Homburger, Tobias Peikert, Gary S. Hoffman, Peter A. Merkel, Robert Spiera, E. William St. Clair, John C. Davis, W. Joseph McCune, Andrea K. Tibbs, Steven R. Ytterberg, John H. Stone, Ulrich Specks - The American Journal of Medicine 2007 被引用: 292

  18. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

    著者: Ravi Suppiah, Andrew Judge, R.N. Batra, Oliver Floßmann, Lorraine Harper, Peter Höglund, M K Javaid, David Jayne, Chetan Mukhtyar, Kerstin Westman, John C. Davis, Gary S. Hoffman, W. Joseph McCune, Peter A. Merkel, E. William St. Clair, Philip Seo, Robert Spiera, John H. Stone, Raashid Luqmani - Arthritis Care & Research 2011 被引用: 177

  19. Electrical stimulation and denervated muscles after spinal cord injury

    著者: Ashraf S. Gorgey, Subhalakshmi Chandrasekaran, John C. Davis, Ines Bersch, Gary Goldberg - Neural Regeneration Research 2020 被引用: 65

  20. Using multiple logistic regression and GIS technology to predict landslide hazard in northeast Kansas, USA

    著者: Gregory C. Ohlmacher, John C. Davis - Engineering Geology 2003 被引用: 674

  21. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trial

    著者: Kenneth Kalunian, John C. Davis, Joan T. Merrill, Mark C. Totoritis, David Wofsy, for the IDEC‐131 Lupus Study Group - Arthritis & Rheumatism 2002 被引用: 335

  22. Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study

    著者: Peter A. Merkel, Grace H. Lo, Janet T. Holbrook, Andrea K. Tibbs, Nancy B. Allen, John C. Davis, Gary S. Hoffman, W. Joseph McCune, E. William St. Clair, Ulrich Specks, Robert Spiera, Michelle Petri, John H. Stone - Annals of Internal Medicine 2005 被引用: 307

  23. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

    著者: John C. Davis, D M van der Heijde, J Braun, M Dougados, J Cush, D Clegg, R D Inman, A Kivitz, L Zhou, A Solinger, W Tsuji - Annals of the Rheumatic Diseases 2005 被引用: 190

  24. Minimal Dissolved Oxygen Requirements of Aquatic Life with Emphasis on Canadian Species: a Review

    著者: John C. Davis - Journal of the Fisheries Research Board of Canada 1975 被引用: 578